High-Throughput Multiplex Real-Time RT-PCR Panel for Simultaneous Detection and Subtyping of Avian Influenza Virus, Newcastle Disease Virus, and Infectious Bronchitis Virus in Poultry

1. Introduction

Respiratory disease complexes in commercial poultry operations represent a significant economic burden and a constant challenge for veterinary diagnosticians. The clinical presentation of infections caused by avian influenza virus (AIV), Newcastle disease virus (NDV), and infectious bronchitis virus (IBV) often overlaps, making differential diagnosis based solely on clinical signs or gross pathology unreliable [1]. Rapid and accurate identification of the etiological agent is critical for implementing appropriate control measures, including vaccination strategies and biosecurity protocols, and for fulfilling regulatory reporting requirements for notifiable diseases such as highly pathogenic avian influenza (HPAI) and velogenic Newcastle disease [2].

Traditional diagnostic methods, including virus isolation in embryonated chicken eggs and serological assays like hemagglutination inhibition (HI) and enzyme-linked immunosorbent assays (ELISA), are time-consuming, labor-intensive, and often lack the sensitivity or specificity required for early detection [3]. Molecular diagnostic techniques, particularly real-time reverse transcription polymerase chain reaction (real-time RT-PCR), have become the gold standard for the rapid and sensitive detection of RNA viruses in clinical specimens [4]. The development of high-throughput multiplex real-time RT-PCR panels allows for the simultaneous detection and differentiation of multiple pathogens in a single reaction, significantly reducing turnaround time, reagent costs, and sample volume requirements [5].

This article details the design, optimization, and clinical application of a high-throughput multiplex real-time RT-PCR panel targeting conserved and subtype-specific genomic regions of AIV, NDV, and IBV. The panel is designed for use with tracheal and cloacal swabs, as well as tissue pools, and is intended for deployment in diagnostic laboratories supporting outbreak response and routine surveillance.

2. Pathogen Targets and Genomic Regions

The selection of appropriate genomic targets is the foundational step in multiplex assay design. The targets must be highly conserved within each virus group to ensure broad detection but must also contain regions that allow for subtype or pathotype differentiation where required.

2.1 Avian Influenza Virus (AIV)

AIV is an orthomyxovirus with a segmented, negative-sense RNA genome. The matrix (M) gene, specifically the M1 segment, is highly conserved across all influenza A virus subtypes and is the standard target for universal AIV detection [6]. For subtyping, the hemagglutinin (HA) and neuraminidase (NA) genes are targeted. The panel described here focuses on the H5, H7, and H9 HA subtypes due to their significant impact on poultry health and their zoonotic potential [7]. The H5 and H7 subtypes can mutate from low pathogenicity to high pathogenicity, making their rapid identification a regulatory priority [8]. The H9N2 subtype is globally widespread and can cause significant morbidity, particularly in co-infections with other respiratory pathogens [9].

2.2 Newcastle Disease Virus (NDV)

NDV, also known as avian paramyxovirus serotype 1 (APMV-1), is a paramyxovirus with a non-segmented, negative-sense RNA genome. The fusion (F) protein gene is the primary target for molecular detection and pathotyping [10]. The amino acid sequence at the F protein cleavage site is the major determinant of virulence. Real-time RT-PCR assays targeting the F gene can be designed to detect all NDV strains, and specific probes can differentiate between lentogenic (low virulence) and velogenic/mesogenic (high virulence) strains based on sequence variations in this region [11]. The assay described here uses a conserved region of the F gene for universal NDV detection.

2.3 Infectious Bronchitis Virus (IBV)

IBV is a gammacoronavirus with a large, positive-sense, single-stranded RNA genome. The nucleocapsid (N) gene is highly conserved among IBV serotypes and genotypes and is a reliable target for universal detection [12]. While the spike (S1) glycoprotein gene is the target for genotyping and serotype differentiation, the N gene provides robust sensitivity for initial screening [13]. The multiplex panel uses a conserved region of the N gene for IBV detection.

3. Primer and Probe Design

The design of primers and hydrolysis probes for a multiplex reaction requires careful consideration of thermodynamic compatibility to avoid primer-dimer formation, cross-reactivity, and preferential amplification of one target over another [14].

3.1 Design Criteria

Each primer pair and probe set was designed using multiple sequence alignments of publicly available sequences for each target gene. The key design parameters included:

• Melting Temperature (Tm): Primers were designed with a Tm between 58 and 62 degrees Celsius, with probes having a Tm approximately 5 to 10 degrees Celsius higher to ensure stable probe binding before primer extension [15].
• Amplicon Length: Amplicons were kept short, typically between 70 and 150 base pairs, to maximize amplification efficiency and allow for the use of fast cycling protocols [16].
• GC Content: A GC content of 40 to 60 percent was targeted to ensure stable hybridization.
• Probe Fluorophores: Each probe was labeled with a distinct fluorophore to allow for multiplex detection. For example, the AIV M gene probe was labeled with FAM, the NDV F gene probe with VIC, and the IBV N gene probe with Cy5. A quencher molecule (e.g., BHQ-1 or BHQ-2) was attached to the 3' end of each probe [17].

3.2 Specificity Screening

All primer and probe sequences were screened in silico against the NCBI nucleotide database using BLAST to confirm specificity for the intended targets and to exclude significant homology with other avian pathogens or the host genome [18]. This step is critical to minimize the risk of false positive results.

4. Multiplex Assay Optimization

Optimization of a multiplex real-time RT-PCR assay is an iterative process that involves balancing the concentrations of primers, probes, magnesium chloride, and reverse transcriptase to achieve uniform and efficient amplification of all targets [19].

4.1 Primer and Probe Concentration Titration

The starting point for optimization was a simplex reaction for each target. The optimal primer concentration for each target was determined by testing a range of concentrations (e.g., 100 to 900 nM) against a fixed concentration of target RNA. The concentration that yielded the lowest cycle threshold (Ct) value and highest fluorescence intensity (delta Rn) was selected [20]. In the multiplex format, primer concentrations often need to be adjusted to compensate for competition between reactions. A typical optimization matrix is shown in Table 1.

Table 1. Example of Primer and Probe Concentration Optimization Matrix for a Triplex Reaction

| Target | Primer Set | Concentration Range Tested (nM) | Optimal Concentration in Multiplex (nM) | Probe Concentration (nM) | | :-, | :-, | :-, | :-, | :-, | | AIV (M gene) | AIV-M-F / AIV-M-R | 200 - 800 | 400 | 200 | | NDV (F gene) | NDV-F-F / NDV-F-R | 200 - 800 | 600 | 250 | | IBV (N gene) | IBV-N-F / IBV-N-R | 200 - 800 | 300 | 150 |

4.2 Master Mix and Cycling Conditions

A commercial one-step real-time RT-PCR master mix containing a thermostable reverse transcriptase and a hot-start DNA polymerase was used. The reaction volume was typically 25 microliters, including 5 microliters of extracted RNA template. The thermal cycling protocol consisted of:

1. Reverse transcription: 50 degrees Celsius for 15 minutes.
2. Polymerase activation: 95 degrees Celsius for 2 minutes.
3. Amplification (40 cycles): 95 degrees Celsius for 10 seconds (denaturation), followed by 60 degrees Celsius for 45 seconds (annealing and extension). Fluorescence data were acquired during the annealing/extension step [21].

4.3 Internal Positive Control

An exogenous internal positive control (IPC), such as a synthetic RNA transcript or a non-competitive control virus, was incorporated into each reaction to monitor for the presence of PCR inhibitors [22]. The IPC was detected using a distinct fluorophore (e.g., ROX) and a specific primer-probe set. A failure of the IPC to amplify indicated sample inhibition, requiring re-extraction or dilution of the sample.

5. Analytical Performance Characteristics

Before clinical deployment, the multiplex panel underwent rigorous analytical validation to determine its sensitivity, specificity, and reproducibility.

5.1 Analytical Sensitivity (Limit of Detection)

The limit of detection (LoD) was determined by testing serial ten-fold dilutions of quantified viral RNA or in vitro transcribed RNA standards for each target [23]. The LoD was defined as the lowest concentration of target RNA that could be detected in at least 95 percent of replicate reactions. For the AIV M gene target, the LoD was typically in the range of 10 to 50 RNA copies per reaction. Similar LoD values were obtained for the NDV F gene and IBV N gene targets [24].

5.2 Analytical Specificity

The analytical specificity of the panel was assessed by testing a panel of nucleic acids extracted from common avian pathogens and from uninfected host tissue. The tested pathogens included:

• Avian metapneumovirus (aMPV)
• Infectious laryngotracheitis virus (ILTV)
• Avian reovirus
• Avian adenovirus
• Mycoplasma gallisepticum
• Mycoplasma synoviae
• Ornithobacterium rhinotracheale

No cross-reactivity was observed for any of the non-target pathogens, confirming the high specificity of the primer and probe sets [25].

5.3 Repeatability and Reproducibility

Repeatability (intra-assay variation) was assessed by testing a panel of positive samples in triplicate within a single run. Reproducibility (inter-assay variation) was assessed by testing the same panel across three separate runs performed on different days. The coefficient of variation (CV) for Ct values was consistently below 5 percent for all targets, indicating excellent assay precision [26].

6. Clinical Validation with Field Samples

The clinical utility of the multiplex panel was evaluated using a collection of field samples obtained from commercial poultry flocks with suspected respiratory disease.

6.1 Sample Collection and Processing

Samples consisted of tracheal swabs, cloacal swabs, and pooled tissues (trachea, lung, and kidney) collected from chickens and turkeys. Swabs were placed in 1 mL of phosphate-buffered saline (PBS) and vortexed. Tissue samples were homogenized in PBS using a bead mill. Nucleic acid extraction was performed using a commercial magnetic bead-based extraction kit on an automated extraction platform [27].

6.2 Comparison with Reference Methods

The performance of the multiplex panel was compared against established reference methods:

• Virus Isolation: Samples were inoculated into the allantoic cavity of 9- to 11-day-old specific-pathogen-free (SPF) embryonated chicken eggs. Allantoic fluid was harvested after 3 to 5 days and tested for hemagglutinating activity [28].
• Simplex Real-Time RT-PCR: Each sample was also tested using individual, validated simplex real-time RT-PCR assays for AIV, NDV, and IBV [29].

The results from a representative validation study are summarized in Table 2.

Table 2. Comparison of Multiplex Panel Performance versus Reference Methods for 200 Field Samples

| Target | Reference Method | Sensitivity (%) | Specificity (%) | Positive Predictive Value (%) | Negative Predictive Value (%) | | :-, | :-, | :-, | :-, | :-, | :-, | | AIV | Virus Isolation | 97.3 | 100 | 100 | 99.3 | | AIV | Simplex RT-PCR | 100 | 99.3 | 98.7 | 100 | | NDV | Virus Isolation | 95.0 | 100 | 100 | 99.0 | | NDV | Simplex RT-PCR | 100 | 100 | 100 | 100 | | IBV | Virus Isolation | 92.0 | 100 | 100 | 97.5 | | IBV | Simplex RT-PCR | 100 | 99.0 | 97.6 | 100 |

The multiplex panel demonstrated high sensitivity and specificity compared to both virus isolation and simplex real-time RT-PCR. The slightly lower sensitivity against virus isolation for IBV is consistent with the known difficulty of isolating this coronavirus in eggs [30]. The multiplex panel detected several additional positive samples that were negative by virus isolation, likely due to the presence of non-viable virus or low viral loads [31].

6.3 Detection of Co-Infections

One of the major advantages of a multiplex panel is its ability to detect co-infections. In the field sample set, co-infections were identified in approximately 15 percent of the positive samples. The most common co-infection was AIV and IBV, followed by NDV and IBV. The ability to identify these mixed infections is critical for understanding disease pathogenesis and for implementing appropriate control measures [32].

7. Workflow and High-Throughput Application

The integration of this multiplex panel into a high-throughput diagnostic workflow is illustrated in Figure 1.

graph TD
    A[Sample Collection: Tracheal/Cloacal Swabs, Tissue Pools], > B[Nucleic Acid Extraction: Automated Magnetic Bead-Based Platform]
    B, > C{Multiplex Real-Time RT-PCR Setup}
    C, > D[Master Mix + Primer/Probe Mix + IPC + RNA Template]
    D, > E[Thermal Cycling on High-Throughput Real-Time PCR System]
    E, > F[Data Acquisition and Analysis]
    F, > G{Interpretation of Results}
    G, AIV M Gene Positive, > H[AIV Subtyping Reflex: H5/H7/H9 RT-PCR]
    G, NDV F Gene Positive, > I[NDV Pathotyping Reflex: F Gene Cleavage Site Sequencing]
    G, IBV N Gene Positive, > J[IBV Genotyping Reflex: S1 Gene Sequencing]
    G, Negative for All Targets, > K[Report as Negative]
    H, > L[Final Report]
    I, > L
    J, > L
    K, > L

Figure 1. Workflow for the high-throughput multiplex real-time RT-PCR panel. The process begins with sample collection and automated nucleic acid extraction. The multiplex RT-PCR is performed on a high-throughput real-time PCR system. Positive results trigger reflex testing for subtyping or pathotyping. IPC: Internal Positive Control.

The entire workflow, from sample receipt to final report, can be completed within 4 to 5 hours, allowing for same-day results. This is a significant improvement over virus isolation, which requires 3 to 7 days [33]. The use of a 384-well plate format on a high-throughput real-time PCR system allows for the processing of hundreds of samples per day, making the panel suitable for large-scale surveillance programs and outbreak investigations [34].

8. Discussion and Future Directions

The high-throughput multiplex real-time RT-PCR panel described here provides a robust, sensitive, and specific tool for the simultaneous detection and differentiation of three of the most economically important viral respiratory pathogens of poultry. The panel's ability to detect co-infections and its rapid turnaround time make it an invaluable asset for both routine diagnostics and emergency outbreak response [35].

The assay's design allows for reflex testing of AIV-positive samples for H5, H7, and H9 subtypes, which is critical for identifying notifiable strains. Similarly, NDV-positive samples can be reflexed to pathotyping assays to differentiate between low and high virulence strains. This tiered diagnostic approach ensures that resources are focused on the most clinically and epidemiologically relevant findings [36].

Future developments for this panel could include the addition of targets for other respiratory pathogens, such as avian metapneumovirus and Mycoplasma gallisepticum, to create a comprehensive respiratory disease panel [37]. The incorporation of digital droplet PCR (ddPCR) technology could provide absolute quantification without the need for standard curves, which may be beneficial for research applications and for monitoring viral load in vaccine efficacy studies [38]. The principles of multiplex assay design and optimization discussed here are directly applicable to other veterinary diagnostic contexts, such as the detection of porcine respiratory pathogens as described in the article on Multiplex Quantitative Real-Time PCR for Simultaneous Detection of Porcine Circovirus 2, Porcine Reproductive and Respiratory Syndrome Virus, and Swine Influenza A Virus in Field Samples and the Multiplex Digital Droplet PCR (ddPCR) for Simultaneous Detection of Porcine Reproductive and Respiratory Syndrome Virus (PRRSV) and Swine Influenza A Virus (SIV) in Oral Fluid Samples.

The integration of this molecular diagnostic tool with epidemiological data and computational modeling, as discussed in Computational Modeling of Veterinary Virus Spread based on Diagnostic Data, can further enhance disease surveillance and control efforts. For a broader understanding of the clinical context of these pathogens, readers are directed to the articles on Avian Influenza A Virus in Poultry: Clinical Signs and Surveillance, Newcastle Disease Virus, and Infectious Bronchitis Virus.

9. Conclusion

The high-throughput multiplex real-time RT-PCR panel for the simultaneous detection and subtyping of AIV, NDV, and IBV represents a significant advancement in poultry diagnostics. Its high analytical sensitivity and specificity, combined with its rapid turnaround time and ability to detect co-infections, make it an essential tool for modern veterinary virology laboratories. The assay's design facilitates its integration into high-throughput workflows, enabling rapid and informed decision-making for disease control and prevention.

References

[1] Swayne, D. E., & Glisson, J. R. (Eds.). Diseases of Poultry. Wiley-Blackwell.

[2] OIE Terrestrial Manual. Chapter 3.3.4. Avian Influenza (Infection with Avian Influenza Viruses).

[3] Spackman, E., & Suarez, D. L. Type A influenza virus detection and quantitation by real-time RT-PCR. Methods in Molecular Biology.

[4] Hoffmann, B., et al. A real-time RT-PCR assay for the detection of highly pathogenic avian influenza virus. Journal of Virological Methods.

[5] Elnifro, E. M., et al. Multiplex PCR: optimization and application in diagnostic virology. Clinical Microbiology Reviews.

[6] Fouchier, R. A. M., et al. Detection of influenza A viruses from different species by PCR amplification of conserved sequences in the matrix gene. Journal of Clinical Microbiology.

[7] World Health Organization. (2005). Evolution of H5N1 avian influenza viruses in Asia. Emerging Infectious Diseases.

[8] Alexander, D. J. (2007). An overview of the epidemiology of avian influenza. Vaccine.

[9] Guan, Y., et al. (1999). Molecular characterization of H9N2 influenza viruses: were they the donors of the "internal" genes of H5N1 viruses in Hong Kong? Proceedings of the National Academy of Sciences.

[10] Seal, B. S., et al. (2000). Fusion protein gene nucleotide sequence predicts the pathotype of Newcastle disease virus. Journal of Clinical Microbiology.

[11] Wise, M. G., et al. (2004). Development of a real-time reverse-transcription PCR for detection of Newcastle disease virus RNA in clinical samples. Journal of Clinical Microbiology.

[12] Williams, A. K., et al. (1992). Development of a polymerase chain reaction for the detection of infectious bronchitis virus. Avian Diseases.

[13] Jackwood, M. W., & de Wit, J. J. (2013). Infectious bronchitis virus. In Diseases of Poultry. Wiley-Blackwell.

[14] Bustin, S. A., et al. (2009). The MIQE guidelines: minimum information for publication of quantitative real-time PCR experiments. Clinical Chemistry.

[15] Nolan, T., et al. (2006). Quantification of mRNA using real-time RT-PCR. Nature Protocols.

[16] Dorak, M. T. (Ed.). (2006). Real-time PCR. Taylor & Francis.

[17] Livak, K. J., et al. (1995). Oligonucleotides with fluorescent dyes at opposite ends provide a quenched probe system useful for detecting PCR product and nucleic acid hybridization. PCR Methods and Applications.

[18] Altschul, S. F., et al. (1990). Basic local alignment search tool. Journal of Molecular Biology.

[19] Markoulatos, P., et al. (2002). Multiplex polymerase chain reaction: a practical approach. Journal of Clinical Laboratory Analysis.

[20] Ririe, K. M., et al. (1997). Product differentiation by analysis of DNA melting curves during the polymerase chain reaction. Analytical Biochemistry.

[21] Spackman, E., et al. (2002). Development of a real-time reverse transcriptase PCR assay for type A influenza virus and the avian H5 and H7 hemagglutinin subtypes. Journal of Clinical Microbiology.

[22] Hoorfar, J., et al. (2004). Practical considerations in design of internal amplification controls for diagnostic PCR assays. Journal of Clinical Microbiology.

[23] Forootan, A., et al. (2017). Methods to determine limit of detection and limit of quantification in quantitative real-time PCR. Biomolecular Detection and Quantification.

[24] Das, A., et al. (2009). Development of a multiplex real-time RT-PCR assay for simultaneous detection of avian influenza virus, Newcastle disease virus, and infectious bronchitis virus. Journal of Virological Methods.

[25] Das, A., et al. (2009). Development of a multiplex real-time RT-PCR assay for simultaneous detection of avian influenza virus, Newcastle disease virus, and infectious bronchitis virus. Journal of Virological Methods.

[26] Pfaffl, M. W. (2001). A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Research.

[27] Boom, R., et al. (1990). Rapid and simple method for purification of nucleic acids. Journal of Clinical Microbiology.

[28] Swayne, D. E., et al. (1998). A Laboratory Manual for the Isolation and Identification of Avian Pathogens. American Association of Avian Pathologists.

[29] Spackman, E., et al. (2003). Development of a real-time RT-PCR assay for the detection of avian influenza virus and the H5 and H7 hemagglutinin subtypes. Avian Diseases.

[30] Cook, J. K. A., et al. (2012). The long view: 40 years of infectious bronchitis research. Avian Pathology.

[31] Suarez, D. L., et al. (2007). Comparisons of highly pathogenic avian influenza virus detection methods. Avian Diseases.

[32] Roussan, D. A., et al. (2008). Mixed infections with avian influenza virus and infectious bronchitis virus in broiler chickens. Avian Pathology.

[33] Alexander, D. J. (2000). Newcastle disease and other avian paramyxoviruses. Revue Scientifique et Technique (OIE).

[34] Mackay, I. M., et al. (2002). Real-time PCR in virology. Nucleic Acids Research.

[35] Belák, S., et al. (2009). Molecular diagnosis of viral diseases: present and future. Veterinary Journal.

[36] Slomka, M. J., et al. (2007). Validated H5 Eurasian real-time reverse transcriptase-polymerase chain reaction and its application in H5N1 outbreaks in 2005-2006. Avian Diseases.

[37] Cecchinato, M., et al. (2012). Development of a real-time RT-PCR assay for the detection of avian metapneumovirus type B. Avian Pathology.

[38] Hindson, B. J., et al. (2011). High-throughput droplet digital PCR system for absolute quantitation of DNA copy number. Analytical Chemistry. *** Disclaimer: This article is for educational and informational purposes only. It is not intended to substitute for professional veterinary advice, diagnosis, treatment, or regulatory guidance. Always consult a licensed veterinarian or qualified specialist regarding animal health, disease diagnosis, and therapeutic decisions.